What's NextThis from Stockwatch June 15th
RepliCel expects to file 2021 financials by June 30
RepliCel Life Sciences Inc. is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 -- Management Cease Trade Orders. On May 3, 2022, the company announced that it made an application to the British Columbia Securities Commission to approve a temporary management cease trade order (MCTO) on the basis that it would be unable to file its annual financial statements, accompanying management's discussion and analysis, and required certifications for the year ended Dec. 31, 2021, on or before the prescribed filing deadline of May 2, 2022, as required by National Instrument 51-102 -- Continuous Disclosure Obligations, and NI 52-109 -- C
With this MCTO in place until June 30th I imagine along with insiders having a cease trading in place it also may include not releasing any pertinent information.
Hopefully after June 30th we may see some long awaited information as to what is going on with this company. Let's hope it is good news after such a long wait.